基因合成市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPHE100001214
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 150
Buy Now

[研究报告]2017年医疗保健市场的基因合成价值为399123万美元,预计到2025年将达到10779782万美元;预计2017年至2025年复合年增长率为28.7%。

这份研究报告提供了对全球基因合成市场的见解。基因合成是一种合成生物学技术,用于在实验室中创建人工基因。该方法基于固相 DNA 合成,与分子克隆和聚合酶链式反应 (PCR) 不同。基因合成用于分子克隆、创建融合蛋白或实现足够高的蛋白质表达水平。与传统的分子克隆技术相比,基因合成服务有助于节省时间和金钱,同时提供无与伦比的自上而下的可定制性。推动这个市场的因素是投资的增加和投资的增加。基因合成资金、初创公司数量的增加和技术进步是市场增长的关键驱动力。然而,缺乏熟练的专业人员和漫长的审批流程等因素可能会在一定程度上限制市场的增长。

医疗保健市场的基因合成预计将持续增长。见证大流行后的大幅增长。由于封锁、旅行禁令和企业关闭,COVID-19 已经影响了各国的经济和行业。 COVID-19 危机使许多国家的公共卫生系统负担过重,凸显了对卫生系统可持续投资的强烈需求。随着 COVID-19 大流行的进展,医疗保健行业的增长预计将下降。由于体外诊断产品需求的增加以及全球研发活动的增加,生命科学领域蓬勃发展。然而,由于进行的手术数量减少以及设备采购推迟或延长,医疗技术和成像领域的销售额正在下降。此外,医疗保健专业人员的虚拟咨询预计将成为大流行后的主流护理服务模式。随着远程医疗改变医疗服务方式,数字医疗将在未来几年继续蓬勃发展。此外,临床试验的中断以及随后药物上市的延迟预计也将为未来的完全虚拟试验铺平道路。 mRNA 等新技术预计将出现并改变制药行业,未来几年市场预计还将出现更多的垂直整合和合资企业。

利润丰厚的地区医疗保健市场中的基因合成


市场洞察

基因合成在医疗保健中的不断增长的应用将推动基因合成在医疗保健市场的增长

< p>基因合成是重组 DNA 技术领域最被接受的工具,其中包括重组蛋白生产。例如,2018 年 7 月,英国创新机构 Innovate UK 资助了约 176 万美元(130 万英镑)的项目 Evonetix Ltd(英国),该项目将与杜伦大学合作。该资金将用于开发一种新的 DNA 合成酶法。此外,2018年4月,DNA Script获得了欧盟委员会和Bpifrance(法国投资银行)约550万美元的资助资金。技术平台和其他相关资源正在帮助公司加速基因合成的发展。公司还增加了研发资金用于增强基因合成。此外,2016年,Twist Bioscience增加了6100万美元的收入,用于基于硅芯片的高通量低成本基因合成平台的放大和商业运营。

在全球范围内,基因合成以其创新和动态结果树立了标杆。该行业吸引了全球众多领先企业投资基因合成。例如,2017 年 11 月,Bolt Threads 在 D 轮融资中筹集了 1.23 亿美元,由 Ballie Gifford 以及上述 Formation 8、Founders Fund、Fidelity Management、Research Company 和淡马锡等其他公司领投。艾伦与有限责任公司。 Bolt Threads 还在 TechCrunch 上宣布,其 D 轮融资金额已增加至 2.13 亿美元。此外,2015 年,Zymergen 还获得了来自 Transcript、AME Cloud Ventures、Data Collective、Draper Fisher Jurvetson、HVF、Innovation Endeavors、Obvious Ventures、True Ventures 和 Two Sigma Ventures 等投资者的 4400 万美元资金。

下表列出了各国在生物技术开发方面的投资。

2018 年 3 月,SynbiCITE(英国)获得了约 1760 万美元(1300 万英镑)的资助,私人投资 3.185 亿美元(2.34 亿英镑)。重要的是,SynbiCITE 是为了增加英国的 Synbio 应用而设计的。 SynbiCITE 在国家层面支持 synbio 以增加基因合成应用。因此,政府和公司的巨额投资预计将在预测几年内增加全球基因合成市场的增长。

越来越多的新进入者进行基因合成程序是推动全球基因合成市场增长的主要因素之一。由于加速器的支持,初创企业正在激增,以促进和商业开发生物和工程应用。各地区政府的支持为生物技术领域的研发提供充足的资金,有助于初创公司寻求建立新企业的基础投资。例如,第一个合成生物学加速器是 Indie Bio(美国加利福尼亚州)和 EU(爱尔兰)。此外,2017年12月,Molecular Assemblies(美国圣地亚哥)开发了一种最新的DNA合成酶法,筹集了230万美元。此外,DNA Script(法国)成立于 2014 年,由 Illumina Ventures 和 Merck Ventures 以及其他投资者 Sofinnova Partners、Kurma Partners 和 Idinvest Partners 领导,筹集了超过 1200 万美元(1100 万欧元)。这些资金和该领域主要参与者的支持帮助该公司将独特的DNA合成技术用于工业规模化。

随着亚洲国家政府为基因合成等生物工程程序的开发提供资金,亚太地区的初创公司数量也有所增加。例如,2018年5月,印度政府向印度理工学院马德拉斯分校资助IITM生物孵化器,作为最先进的癌症生物学研究设施,并建立生物信息学基础设施。这些资金由多个机构提供,例如 CSIR、DAE、DBT 和 DST 等。同样,在中国,中国加速是一家通过帮助初创企业提供导师计划的融资机构。它通过在 RebelBio 和 Indie Bio 等项目下为公司提供风险投资来帮助初创企业的建立。先进生物技术方法创新概念的资金可用性激励全球企业家建立新公司并提供基因合成服务。因此,上述因素可能会在预测期内支持市场增长。

 

基于产品和服务的见解

服务部门持有产品和产品的主要市场份额服务领域。 2017年,按产品和服务分类,服务领域占据基因合成市场最大的市场份额,占51.1%。服务。由于分析和数据管理解决方案、服务合作伙伴关系和金融解决方案,预计该细分市场将在 2025 年占据市场主导地位。此外,预计服务领域在 2018 年至 2025 年的预测期内将出现最快的增长率。

医疗保健市场中的基因合成(按产品和服务划分) 2017 年和 2025 年


基于应用程序的见解

研究与预测开发活动部分预计将根据应用主导市场。研究与研究发展活动部分预计在预测期内复合年增长率为 30.9%。研发有助于构建变异文库、基因、操纵子,增强蛋白质功能,并测试特定基因,预计将在未来几年增加对乳房植入物的需求。

 < /h3>

基于最终用户的见解

学术与实践研究机构部门可能会在最终用户中主导市场。 2017年,学术与研究按技术划分,研究机构部门在基因合成市场中占有最大的市场份额,占 45.5%。预计该细分市场将在 2025 年占据市场主导地位。预计 2018 年至 2025 年预测期内,制药公司细分市场将实现 30.1% 的最快增长率。该细分市场的较高增长率归因于政府资金的增加以及各地区各组织之间的合作伙伴关系的增加


战略洞察

医疗保健市场中的基因合成参与者正在采用产品推出和扩张策略来满足全球不断变化的客户需求,这也使他们能够在全球范围内维持其品牌名称。< /p>

 

医疗保健市场中的基因合成 –按产品和服务

  • 软件
  • 消耗品
  • 服务

医疗保健市场中的基因合成;按应用划分

  • 研究与应用开发活动
  •  诊断
  •  治疗
  •  其他

医疗保健市场中的基因合成–按最终用户

  • 学术和研究机构
  • 制药和研究机构生物技术公司
  • 诊断实验室
  • 其他

医疗保健市场中的基因合成 -按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲 (SCAM)
    • 巴西
    • 阿根廷
    • 其他 SCAM
  • < /ul>

     

    公司简介

    • Eurofins Scientific
    • Thermo Fisher Scientific Inc.
    • 金斯瑞 < /li>
    • BIONEER CORPORATION
    • 集成 DNA 技术
    • ATUM
    • Twist Bioscience
    • BioCat GmbH
    • OriGene Technologies, Inc.
    • GENEWIZ。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. Thermo Fisher Scientific Inc
2. Integrated DNA Technologies, Inc.
3. Twist Bioscience
4. OriGene Technologies, Inc.
5. BioCat GmbH
6. GenScript
7. Eurofins Scientific
8. Bioneer Corporation
9. ATUM
10. GENEWIZ

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports